我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Mucosal Immunopathology: Understanding the Complex Interplay of Host Immune Responses at Mucosal Surfaces

Shiwani P

Mucosal surfaces, such as the respiratory, gastrointestinal, and genitourinary tracts, serve as critical entry points for a wide range of pathogens, allergens, and environmental factors. The immune system deployed at these sites is uniquely designed to maintain a delicate balance between providing protection against invading pathogens while tolerating harmless antigens, including commensal microorganisms. Mucosal immunopathology encompasses the study of dysregulated immune responses and their associated tissue damage and dysfunction at these mucosal surfaces. This abstract provides a comprehensive overview of the current understanding of mucosal immunopathology, highlighting the intricate interplay between the immune system and various mucosal barriers. It explores the complex mechanisms by which mucosal immunity modulates both innate and adaptive immune responses to maintain homeostasis, regulate inflammation, and protect against infections. Furthermore, this abstract delves into the dysregulated immune responses observed in various mucosal immunopathologies, including inflammatory bowel disease, asthma, chronic rhinosinusitis, and sexually transmitted infections. It examines the contribution of genetic predisposition, environmental triggers, dysbiosis, and impaired mucosal barrier function in initiating and perpetuating mucosal inflammation and tissue damage. The abstract also sheds light on emerging research strategies aimed at understanding the underlying mechanisms of mucosal immunopathology, including the role of epithelial cells, mucin production, immune cell subsets, and the intricate interplay of pro-inflammatory and anti-inflammatory mediators. Additionally, it highlights the potential therapeutic interventions targeting mucosal immunopathology, such as immune-modulating drugs, targeted biologics, and microbiota-based therapies.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。